IGF1R and breast carcinoma: These findings suggest that a vicious self-augmenting feedback loop between GASP1 and the IGF1/IGF1R-related pathways not only promotes the malignant progression of breast cancer but also contributes to the resistance of breast cancer cells to paclitaxel.